Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Moderna's stock has been under scrutiny following its recent announcement of a revised financial plan and updates to its mRNA-based pipeline. CEO On Thursday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Moderna Inc (NASDAQ:MRNA). This decision comes amidst a backdrop of mixed analyst sentiments and Moderna's recently unveiled post-COVID roadmap.
上周四，凯西·伍德领导的Ark Invest通过抛售Moderna Inc（纳斯达克：moderna）股份做出了重大举动。 这一决定是在分析师情绪褒贬不一和Moderna最近公布的疫情后路线图背景下做出的。
The Moderna Trade
Moderna交易
Ark Invest's ARK Genomic Revolution ETF (BATS:ARKG) and ARK Innovation ETF (NYSE:ARKK) sold a total of 160,994 shares of Moderna. The value of the trade, based on Moderna's closing price of $56.83 on the day of the trade, is approximately $9.15 million.
Ark Invest的ark生物基因科技革新主动型etf（BATS：arkg）和ark创新etf（纽交所：arkk）共出售了160,994股Moderna。 根据交易日Moderna收盘价56.83美元的数据，交易价值约为915万美元。
Moderna's stock has been under scrutiny following its recent announcement of a revised financial plan and updates to its mRNA-based pipeline. CEO Stéphane Bancel highlighted the company's success in respiratory vaccines and outlined a focus on five non-respiratory products aiming for approvals by 2027.
近期，Moderna股票因其修订后的财务计划公告以及其基于mRNA的管线更新而受到关注。CEO斯特凡·班塞尔强调了公司在呼吸疫苗方面的成功，并概述了该公司专注于五种非呼吸产品，旨在于2027年获批。
However, the biotech company's future prospects have elicited mixed reactions from analysts. Over the past three months, 16 analysts have shared their evaluations, with the average 12-month price target standing at $111.50, a decrease of 18.06% from the previous average.
然而，这家生物科技公司的未来前景引发了分析师的褒贬不一反应。 在过去的三个月中，有16名分析师分享了他们的评估，平均12个月的价格目标为111.50美元，比上一个平均价格下降了18.06%。
Other Key Trades:
其他关键交易：
ARK Autonomous Technology & Robotics ETF (ARKQ) bought 3,589 shares of Advanced Micro Devices Inc (AMD) worth $589,242.
ark自主科技与机器人etf（arkq）购买了3,589股价值589,242美元的美国超微公司股票。
Ark Invest's ARKG and ARKK bought a total of shares of 10X Genomics Inc (TXG).
Ark Invest的arkg和arkk购买了10X Genomics Inc（TXG）的股票。
ARKK also purchased shares of CRISPR Therapeutics AG (CRSP).
ark也购买了CRISPR Therapeutics AG (CRSP)的股票。
Blade Air Mobility Inc (BLDE), and 3D Systems Corp (DDD) while selling shares of Materialise NV (MTLS) and Markforged Holding Corp (MKFG).
Blade Air Mobility Inc (BLDE)和3D Systems Corp (DDD)的股票，同时出售了Materialise NV (MTLS)和Markforged Holding Corp (MKFG)的股票。
